News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IncellDx, Inc. Announces Successful Presentation of Its Personalized HIV Monitoring Assays at the 5th Santorini Conference in Greece



10/6/2010 9:42:21 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--IncellDx, Inc. announces the presentation of multicenter data by Dr. George Lallas of FlowCytoGen Laboratories at the '5th Santorini Conference on Functional Genomics towards a Personalized Health Care.' Dr. Lallas’ talk described how the combination of the HIV Reservoirs Assay and the HIV Tropism Assay are effective in the determination of efficacy for HIV therapy in individual patients. These assays can be used on individuals over time to monitor and adjust the therapeutic regimen.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES